NCT01933984View on ClinicalTrials.gov

Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated COPD Patients

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Bronchodilators inhalation

Salmeterol/fluticasone (Seretide Evohaler) 4 puffs plus fenoterol (Berotec)(0.1mg/puff) 4 puffs inhalation when target airway resistance, measured every 8 hours, not met

Trial Locations (1)

50006

Changhua Christian Hospital, Changhua

All Listed Sponsors

lead

Shin-hwar Wu

OTHER

NCT01933984 - Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated COPD Patients | Biotech Hunter | Biotech Hunter